None
NL
Leerink Partnrs Has Negative Outlook of Sanofi Q3 Earnings
['Defense World Staff']
Defense World
Get Sanofi alerts:Sanofi (NASDAQ:SNY – Free Report) – Stock analysts at Leerink Partnrs reduced their Q3 2025 earnings per share estimates for Sanofi in a research report issued on Tuesday, September 30th.
Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of $1.58 for the quarter, down from their previous estimate of $1.59.
Sanofi (NASDAQ:SNY – Get Free Report) last announced its quarterly earnings data on Thursday, July 31st.
The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.96 by ($0.06).
Sanofi Company Profile(Get Free Report)Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally.